Vanguard Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $952M | Buy |
|
|||||
|
2025
Q1 | $764M | Buy |
|
|||||
|
2024
Q4 | $956M | Sell |
|
|||||
|
2024
Q3 | $1.21B | Sell |
|
|||||
|
2024
Q2 | $768M | Buy |
|
|||||
|
2024
Q1 | $1.23B | Buy |
|
|||||
|
2023
Q4 | $1.3B | Buy |
|
|||||
|
2023
Q3 | $1.19B | Sell |
|
|||||
|
2023
Q2 | $1.65B | Buy |
|
|||||
|
2023
Q1 | $1.18B | Buy |
|
|||||
|
2022
Q4 | $854M | Buy |
|
|||||
|
2022
Q3 | $542M | Buy |
|
|||||
|
2022
Q2 | $629M | Buy |
|
|||||
|
2022
Q1 | $1.09B | Buy |
|
|||||
|
2021
Q4 | $1.2B | Buy |
|
|||||
|
2021
Q3 | $1.47B | Sell |
|
|||||
|
2021
Q2 | $1.92B | Buy |
|
|||||
|
2021
Q1 | $1.99B | Buy |
|
|||||
|
2020
Q4 | $1.88B | Buy |
|
|||||
|
2020
Q3 | $1.37B | Sell |
|
|||||
|
2020
Q2 | $1.2B | Sell |
|
|||||
|
2020
Q1 | $799M | Buy |
|
|||||
|
2019
Q4 | $1.24B | Buy |
|
|||||
|
2019
Q3 | $1.07B | Buy |
|
|||||
|
2019
Q2 | $1.36B | Buy |
|
|||||
|
2019
Q1 | $971M | Buy |
|
|||||
|
2018
Q4 | $681M | Buy |
|
|||||
|
2018
Q3 | $829M | Buy |
|
|||||
|
2018
Q2 | $612M | Buy |
|
|||||
|
2018
Q1 | $413M | Buy |
|
|||||
|
2017
Q4 | $528M | Buy |
|
|||||
|
2017
Q3 | $458M | Buy |
|
|||||
|
2017
Q2 | $335M | Buy |
|
|||||
|
2017
Q1 | $207M | Buy |
|
|||||
|
2016
Q4 | $110M | Buy |
|
|||||
|
2016
Q3 | $147M | Buy |
|
|||||
|
2016
Q2 | $87M | Buy |
|
|||||
|
2016
Q1 | $45M | Sell |
|
|||||
|
2015
Q4 | $61.8M | Buy |
|
|||||
|
2015
Q3 | $117M | Buy |
|
|||||
|
2015
Q2 | $176M | Buy |
|
|||||
|
2015
Q1 | $126M | Buy |
|
|||||
|
2014
Q4 | $142M | Buy |
|
|||||
|
2014
Q3 | $97.8M | Buy |
|
|||||
|
2014
Q2 | $85.5M | Buy |
|
|||||
|
2014
Q1 | $62.2M | Buy |
|
|||||
|
2013
Q4 | $49.4M | Buy |
|
|||||
|
2013
Q3 | $48.1M | Buy |
|
|||||
|
2013
Q2 | $53.9M | Buy |
|